(VIANEWS) – VERALLIA (VRLA.PA), HOLLAND COLOURS (HOLCO.AS), SPIE (SPIE.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. VERALLIA (VRLA.PA)
19.7% sales growth and 44.03% return on equity
Verallia Société Anonyme produces and sells glass packaging products for beverages and food industry worldwide. It also provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.08.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 8.24. Meaning, the purchaser of the share is investing €8.24 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.03%.
More news about VERALLIA.
2. HOLLAND COLOURS (HOLCO.AS)
13.8% sales growth and 6.75% return on equity
Holland Colours N.V., together with its subsidiaries, manufactures, distributes, and sells color concentrates in Europe, the Middle East, India, Africa, the Americas, and Asia. The company offers colorants for the building and construction industry, including profiles, pipes, tubing and fittings, siding and cladding, decking, fencing, window blinds, and insulation, as well as solutions for a range of polymers. It also provides colorants for packaging applications comprising water, carbonated soft drinks, fruit juices, dairy, beer, wine, detergents, pharmaceutical, and personal care products. In addition, the company offers coatings, sealants, or adhesives; and colorants for other markets, such as shopping bags, polybags, mulch films, OPP tapes, PU flexible foams, synthetic leather, fiber glass and buttons, paving blocks, artificial stones, cast PMMA, PP non-woven and spunbond, coatings, flexible PVCs, prosthetics, glass fiber reinforced nylon, and silicone rubber and elastomers. It sells its products through a network of agents and distributors. The company was founded in 1979 and is headquartered in Apeldoorn, the Netherlands. Holland Colours N.V. is a subsidiary of Holland Pigments BV.
Earnings Per Share
As for profitability, HOLLAND COLOURS has a trailing twelve months EPS of €4.68.
PE Ratio
HOLLAND COLOURS has a trailing twelve months price to earnings ratio of 17.84. Meaning, the purchaser of the share is investing €17.84 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.75%.
More news about HOLLAND COLOURS.
3. SPIE (SPIE.PA)
7.3% sales growth and 8.32% return on equity
SPIE SA provides multi-technical services in the areas of energy and communications. The company operates through four segments: France; Germany and Central Europe; North-Western Europe; and Oil & Gas and Nuclear. It provides technical engineering solutions for buildings; technical facility management, energy-efficiency, and technical services for the transmission and distribution of energy for industrial clients; and electrical, mechanical, and HVAC engineering services. The company also offers oil and gas services, including exploring and investigating new fields, buildings and operating facilities, and optimizing production; construction, renovation, and maintenance services for bridges, locks, and pumping stations; maintenance and innovative solutions for traffic infrastructure; and fixed and mobile digital telecom networks, as well as technical building management, communications and networks, tech FM services; engineering, construction, maintenance, and optimization services for industrial processes; energy recovery and sustainable management services to technical facilities; and energy transmission networks, medium-voltage facilities, distribution networks, busbar systems, and wind and solar power farms. In addition, it engages in the installation and maintenance of electrical systems, heating and air conditioning, building ventilation, utilities and automation for industries; and management of IT and data processing infrastructures. The company was founded in 1900 and is headquartered in Cergy-Pontoise, France.
Earnings Per Share
As for profitability, SPIE has a trailing twelve months EPS of €0.92.
PE Ratio
SPIE has a trailing twelve months price to earnings ratio of 30.63. Meaning, the purchaser of the share is investing €30.63 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.32%.
Sales Growth
SPIE’s sales growth is 7.8% for the present quarter and 7.3% for the next.
Moving Average
SPIE’s worth is higher than its 50-day moving average of €26.30 and higher than its 200-day moving average of €27.35.
Volume
Today’s last reported volume for SPIE is 41221 which is 78.95% below its average volume of 195881.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 20, 2023, the estimated forward annual dividend rate is 0.77 and the estimated forward annual dividend yield is 2.82%.
More news about SPIE.
4. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 22. Meaning, the purchaser of the share is investing kr22 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VISTIN PHARMA’s EBITDA is 2.33.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 438.54M for the twelve trailing months.
Moving Average
VISTIN PHARMA’s worth is under its 50-day moving average of kr22.72 and below its 200-day moving average of kr22.10.
More news about VISTIN PHARMA.
